Seek Returns logo

GS vs. HIMS: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at GS and HIMS, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolGSHIMS
Company NameThe Goldman Sachs Group, Inc.Hims & Hers Health, Inc.
CountryUnited StatesUnited States
GICS SectorFinancialsHealth Care
GICS IndustryCapital MarketsHealth Care Providers & Services
Market Capitalization218.16 billion USD9.80 billion USD
ExchangeNYSENYSE
Listing DateMay 4, 1999September 13, 2019
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of GS and HIMS by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

GS vs. HIMS: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolGSHIMS
5-Day Price Return-3.55%-7.96%
13-Week Price Return17.70%-30.41%
26-Week Price Return11.05%-26.70%
52-Week Price Return42.80%161.96%
Month-to-Date Return-0.40%-34.45%
Year-to-Date Return25.86%79.40%
10-Day Avg. Volume1.61M24.23M
3-Month Avg. Volume2.19M41.88M
3-Month Volatility21.05%102.99%
Beta1.442.28

Profitability

Return on Equity (TTM)

GS

12.67%

Capital Markets Industry

Max
38.97%
Q3
21.61%
Median
13.77%
Q1
8.31%
Min
-4.25%

GS’s Return on Equity of 12.67% is on par with the norm for the Capital Markets industry, indicating its profitability relative to shareholder equity is typical for the sector.

HIMS

38.17%

Health Care Providers & Services Industry

Max
26.03%
Q3
13.74%
Median
8.26%
Q1
4.13%
Min
-3.62%

HIMS’s Return on Equity of 38.17% is exceptionally high, placing it well beyond the typical range for the Health Care Providers & Services industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

GS vs. HIMS: A comparison of their Return on Equity (TTM) against their respective Capital Markets and Health Care Providers & Services industry benchmarks.

Net Profit Margin (TTM)

GS

12.29%

Capital Markets Industry

Max
66.67%
Q3
35.11%
Median
23.49%
Q1
13.63%
Min
-15.18%

Falling into the lower quartile for the Capital Markets industry, GS’s Net Profit Margin of 12.29% indicates weaker profitability. This means the company retains a smaller portion of each dollar in sales as profit compared to its competitors.

HIMS

9.62%

Health Care Providers & Services Industry

Max
12.40%
Q3
5.93%
Median
1.96%
Q1
0.93%
Min
-6.10%

A Net Profit Margin of 9.62% places HIMS in the upper quartile for the Health Care Providers & Services industry, signifying strong profitability and more effective cost management than most of its peers.

GS vs. HIMS: A comparison of their Net Profit Margin (TTM) against their respective Capital Markets and Health Care Providers & Services industry benchmarks.

Operating Profit Margin (TTM)

GS

15.68%

Capital Markets Industry

Max
86.40%
Q3
46.46%
Median
32.80%
Q1
18.32%
Min
-21.87%

GS’s Operating Profit Margin of 15.68% is in the lower quartile for the Capital Markets industry. This indicates weaker profitability from core operations, which may stem from inefficiencies or competitive pressures on pricing.

HIMS

6.24%

Health Care Providers & Services Industry

Max
19.05%
Q3
10.21%
Median
4.22%
Q1
1.98%
Min
-4.27%

HIMS’s Operating Profit Margin of 6.24% is around the midpoint for the Health Care Providers & Services industry, indicating that its efficiency in managing core business operations is typical for the sector.

GS vs. HIMS: A comparison of their Operating Profit Margin (TTM) against their respective Capital Markets and Health Care Providers & Services industry benchmarks.

Profitability at a Glance

SymbolGSHIMS
Return on Equity (TTM)12.67%38.17%
Return on Assets (TTM)0.89%18.98%
Net Profit Margin (TTM)12.29%9.62%
Operating Profit Margin (TTM)15.68%6.24%
Gross Profit Margin (TTM)38.58%76.20%

Financial Strength

Current Ratio (MRQ)

GS

0.30

Capital Markets Industry

Max
3.76
Q3
1.89
Median
1.01
Q1
0.54
Min
-0.41

For the Capital Markets industry, the Current Ratio is often not the most suitable measure of short-term liquidity.

HIMS

4.98

Health Care Providers & Services Industry

Max
2.01
Q3
1.49
Median
1.30
Q1
0.94
Min
0.17

HIMS’s Current Ratio of 4.98 is exceptionally high, placing it well outside the typical range for the Health Care Providers & Services industry. This indicates a very strong liquidity position, though such a high ratio may also suggest that the company is not using its assets efficiently to generate profits.

GS vs. HIMS: A comparison of their Current Ratio (MRQ) against their respective Capital Markets and Health Care Providers & Services industry benchmarks.

Debt-to-Equity Ratio (MRQ)

GS

9.08

Capital Markets Industry

Max
6.62
Q3
2.84
Median
1.02
Q1
0.32
Min
0.00

The Debt-to-Equity Ratio is often not the primary focus for assessing leverage in the Capital Markets industry.

HIMS

1.72

Health Care Providers & Services Industry

Max
2.17
Q3
1.18
Median
0.74
Q1
0.45
Min
0.00

HIMS’s leverage is in the upper quartile of the Health Care Providers & Services industry, with a Debt-to-Equity Ratio of 1.72. While this approach can boost equity growth, it also exposes the company to greater financial vulnerability.

GS vs. HIMS: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Capital Markets and Health Care Providers & Services industry benchmarks.

Interest Coverage Ratio (TTM)

GS

--

Capital Markets Industry

Max
126.03
Q3
60.98
Median
11.77
Q1
4.95
Min
-36.26

The Interest Coverage Ratio is often not a primary indicator of debt servicing capacity in the Capital Markets industry.

HIMS

--

Health Care Providers & Services Industry

Max
14.47
Q3
7.15
Median
5.45
Q1
2.04
Min
-4.44

Interest Coverage Ratio data for HIMS is currently unavailable.

GS vs. HIMS: A comparison of their Interest Coverage Ratio (TTM) against their respective Capital Markets and Health Care Providers & Services industry benchmarks.

Financial Strength at a Glance

SymbolGSHIMS
Current Ratio (MRQ)0.304.98
Quick Ratio (MRQ)0.304.30
Debt-to-Equity Ratio (MRQ)9.081.72
Interest Coverage Ratio (TTM)----

Growth

Revenue Growth

GS vs. HIMS: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

GS vs. HIMS: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

GS

2.14%

Capital Markets Industry

Max
10.26%
Q3
4.86%
Median
2.78%
Q1
1.22%
Min
0.00%

GS’s Dividend Yield of 2.14% is consistent with its peers in the Capital Markets industry, providing a dividend return that is standard for its sector.

HIMS

0.00%

Health Care Providers & Services Industry

Max
5.38%
Q3
2.22%
Median
0.55%
Q1
0.00%
Min
0.00%

HIMS currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

GS vs. HIMS: A comparison of their Dividend Yield (TTM) against their respective Capital Markets and Health Care Providers & Services industry benchmarks.

Dividend Payout Ratio (TTM)

GS

29.94%

Capital Markets Industry

Max
200.72%
Q3
101.92%
Median
57.97%
Q1
32.36%
Min
0.00%

GS’s Dividend Payout Ratio of 29.94% is in the lower quartile for the Capital Markets industry. This suggests a conservative dividend policy, with a strategic focus on reinvesting profits for future growth.

HIMS

0.00%

Health Care Providers & Services Industry

Max
186.69%
Q3
74.82%
Median
26.76%
Q1
0.00%
Min
0.00%

HIMS has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

GS vs. HIMS: A comparison of their Dividend Payout Ratio (TTM) against their respective Capital Markets and Health Care Providers & Services industry benchmarks.

Dividend at a Glance

SymbolGSHIMS
Dividend Yield (TTM)2.14%0.00%
Dividend Payout Ratio (TTM)29.94%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

GS

13.98

Capital Markets Industry

Max
58.89
Q3
31.00
Median
18.54
Q1
12.09
Min
5.24

GS’s P/E Ratio of 13.98 is within the middle range for the Capital Markets industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

HIMS

50.64

Health Care Providers & Services Industry

Max
55.89
Q3
30.85
Median
21.17
Q1
12.63
Min
0.00

A P/E Ratio of 50.64 places HIMS in the upper quartile for the Health Care Providers & Services industry. This high valuation relative to peers suggests the market holds elevated expectations for the company’s future growth.

GS vs. HIMS: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Capital Markets and Health Care Providers & Services industry benchmarks.

Price-to-Sales Ratio (TTM)

GS

1.72

Capital Markets Industry

Max
14.49
Q3
7.41
Median
4.68
Q1
2.25
Min
0.04

In the lower quartile for the Capital Markets industry, GS’s P/S Ratio of 1.72 indicates its revenue is valued more conservatively than most of its peers. This could present a compelling opportunity if the market has overlooked its sales-generating capabilities.

HIMS

4.87

Health Care Providers & Services Industry

Max
3.10
Q3
1.74
Median
0.67
Q1
0.24
Min
0.00

With a P/S Ratio of 4.87, HIMS trades at a valuation that eclipses even the highest in the Health Care Providers & Services industry. This implies the market has priced in exceptionally optimistic scenarios for future revenue growth, posing considerable valuation risk.

GS vs. HIMS: A comparison of their Price-to-Sales Ratio (TTM) against their respective Capital Markets and Health Care Providers & Services industry benchmarks.

Price-to-Book Ratio (MRQ)

GS

1.75

Capital Markets Industry

Max
9.48
Q3
4.94
Median
2.42
Q1
1.21
Min
0.38

GS’s P/B Ratio of 1.75 is within the conventional range for the Capital Markets industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

HIMS

19.83

Health Care Providers & Services Industry

Max
7.61
Q3
4.32
Median
2.53
Q1
1.14
Min
0.77

At 19.83, HIMS’s P/B Ratio is at an extreme premium to the Health Care Providers & Services industry. This signifies that the market’s valuation is heavily reliant on future potential rather than its current net asset value, which can be a high-risk proposition.

GS vs. HIMS: A comparison of their Price-to-Book Ratio (MRQ) against their respective Capital Markets and Health Care Providers & Services industry benchmarks.

Valuation at a Glance

SymbolGSHIMS
Price-to-Earnings Ratio (TTM)13.9850.64
Price-to-Sales Ratio (TTM)1.724.87
Price-to-Book Ratio (MRQ)1.7519.83
Price-to-Free Cash Flow Ratio (TTM)4.2441.46